Mediclinic shares jump as market anticipates fatter takeover offer
Equity traders bet the Remgro-led consortium is likely to return with a higher bid
09 June 2022 - 10:42
UPDATED 09 June 2022 - 23:12
Mediclinic has rebuffed a £2bn (R38bn) takeover offer from a group of investors that includes its biggest shareholder, Remgro, with its shares having their best day in about eight months as equity traders bet that the Johann Rupert-chaired investment heavyweight is likely to return with a higher bid.
Along with shipping company MSC, in late May, Remgro offered 463p a share for the 55.4% it does not already own in SA’s most valuable hospital group, which is also listed in London...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.